Madrigal Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Oct '25 Oct 9, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
Market Cap	8,238	5,843	3,958	4,522	1,247	1,484	Upgrade
Market Cap Growth	95.80%	47.65%	-12.47%	262.53%	-15.93%	22.64%	Upgrade
Enterprise Value	7,659	5,148	3,512	4,255	1,015	1,240	Upgrade
PE Ratio	-	-14.09	-11.57	-16.85	-5.79	-8.49	Upgrade
PB Ratio	13.90	9.00	11.35	26.62	7.39	7.18	Upgrade
P/TBV Ratio	11.86	8.70	10.67	25.20	7.15	7.16	Upgrade
P/FCF Ratio	-	-14.86	-14.12	-23.34	-7.87	-10.92	Upgrade
P/OCF Ratio	-	-14.90	-14.18	-23.37	-7.88	-10.94	Upgrade
EV/EBITDA Ratio	-	-8.83	-10.74	-16.87	-4.87	-6.99	Upgrade
EV/EBIT Ratio	-	-8.82	-10.73	-16.84	-4.86	-6.97	Upgrade
EV/FCF Ratio	-29.17	-13.09	-12.53	-21.97	-6.41	-9.12	Upgrade
Debt / Equity Ratio	0.18	0.16	0.29	0.25	0.00	0.00	Upgrade
Debt / EBITDA Ratio	-0.15	-0.18	-0.31	-0.17	0.00	0.00	Upgrade
Debt / FCF Ratio	-0.40	-0.26	-0.36	-0.22	0.00	0.00	Upgrade
Inventory Turnover	0.39	0.37	-	-	-	-	Upgrade
Quick Ratio	4.46	5.79	5.35	3.10	3.52	6.10	Upgrade
Current Ratio	5.11	6.10	5.38	3.12	3.54	6.13	Upgrade
Return on Equity (ROE)	-38.87%	-80.35%	-123.98%	-150.12%	-110.92%	-61.61%	Upgrade
Return on Assets (ROA)	-80.22%	-80.58%	-75.86%	-92.33%	-86.55%	-56.70%	Upgrade
Return on Capital (ROIC)	-4971.15%	-9619.86%	-13594.00%	-15199.12%	-11524.81%	-9559.34%	Upgrade
Return on Capital Employed (ROCE)	-97.57%	-97.21%	-99.00%	-132.49%	-110.99%	-62.88%	Upgrade
Earnings Yield	-2.91%	-7.10%	-8.64%	-5.94%	-17.26%	-11.77%	Upgrade
FCF Yield	-3.19%	-6.73%	-7.08%	-4.28%	-12.70%	-9.16%	Upgrade
Buyback Yield / Dilution	-0.56%	-10.83%	-11.54%	-5.03%	-11.81%	-0.30%	Upgrade
Total Shareholder Return	-	-10.83%	-11.54%	-5.03%	-11.81%	-0.30%	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.